Patents by Inventor Katsunori SEMI

Katsunori SEMI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for screening for cancer therapeutic agent
    Patent number: 11519901
    Abstract: The invention aims to provide a method of screening for a therapeutic drug for cancer as a molecular-targeted drug targeting some protein from a number of candidate target proteins, without identifying the true target protein. In particular, the invention provides a method of screening for a therapeutic drug for cancer, including (i) a step of expressing an exogenous cell regulatory factor in a target cancer cell under contact or no contact with a test substance, (ii) a step of confirming change in the cancer cell, and (iii) a step of selecting the test substance as a therapeutic drug for cancer when the change of cancer cell increased under contact with the test substance as compared to no contact therewith.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: December 6, 2022
    Assignee: THE UNIVERSITY OF TOKYO
    Inventors: Yasuhiro Yamada, Katsunori Semi, Knut Woltjen, Yutaka Matsuda
  • METHOD FOR DEHYDRATING DISPERSION OF CHEMICALLY MODIFIED PULP
    Publication number: 20190055694
    Abstract: A method for dehydrating a dispersion of a chemically modified pulp (oxidized pulp, carboxymethylated pulp, or cationized pulp) obtained by chemically modifying a pulp feedstock, characterized by dehydrating the dispersion of a chemically modified pulp by means of a screw press.
    Type: Application
    Filed: November 11, 2016
    Publication date: February 21, 2019
    Applicant: NIPPON PAPER INDUSTRIES CO., LTD.
    Inventors: Riichi MURAMATSU, Katsunori SEMI, Shinji SATO
  • METHOD FOR SCREENING FOR CANCER THERAPEUTIC AGENT
    Publication number: 20180136195
    Abstract: The invention aims to provide a method of screening for a therapeutic drug for cancer as a molecular-targeted drug targeting some protein from a number of candidate target proteins, without identifying the true target protein. In particular, the invention provides a method of screening for a therapeutic drug for cancer, including (i) a step of expressing an exogenous cell regulatory factor in a target cancer cell under contact or no contact with a test substance, (ii) a step of confirming change in the cancer cell, and (iii) a step of selecting the test substance as a therapeutic drug for cancer when the change of cancer cell increased under contact with the test substance as compared to no contact therewith.
    Type: Application
    Filed: April 1, 2016
    Publication date: May 17, 2018
    Applicants: KYOTO UNIVERSITY, CHUGAI SEIYAKU KABUSHIKI KAISHA
    Inventors: Yasuhiro YAMADA, Katsunori SEMI, Knut WOLTJEN, Yutaka MATSUDA